Greenwood Capital Associates LLC Incyte Corp Transaction History

Greenwood Capital Associates LLC

  • $755 Million
  • Q3 2024

A detailed history of Greenwood Capital Associates LLC transactions in Incyte Corp stock. As of the latest transaction made, Greenwood Capital Associates LLC holds 6,546 shares of INCY stock, worth $454,292. This represents 0.06% of its overall portfolio holdings.

Number of Shares
6,546
Holding current value
$454,292
% of portfolio
0.06%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024
BUY
$57.33 - $68.61 $375,282 - $449,121
6,546 New
6,546 $432,000
Q1 2023

May 12, 2023
SELL
$70.23 - $86.01 $4.08 Million - $5 Million
-58,130 Reduced 88.35%
7,667 $554,000
Q4 2022

Jan 26, 2023
SELL
$67.18 - $84.11 $170,301 - $213,218
-2,535 Reduced 3.71%
65,797 $0
Q3 2022

Nov 10, 2022
BUY
$66.18 - $82.86 $85,372 - $106,889
1,290 Added 1.92%
68,332 $4.55 Million
Q2 2022

Aug 10, 2022
BUY
$66.18 - $83.18 $4.44 Million - $5.58 Million
67,042 New
67,042 $5.09 Million
Q2 2021

Aug 16, 2021
SELL
$79.87 - $87.53 $5.76 Million - $6.31 Million
-72,069 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$76.02 - $100.5 $2.1 Million - $2.77 Million
27,611 Added 62.11%
72,069 $5.86 Million
Q4 2020

Feb 09, 2021
SELL
$80.74 - $97.7 $969,525 - $1.17 Million
-12,008 Reduced 21.27%
44,458 $3.87 Million
Q3 2020

Nov 12, 2020
BUY
$85.07 - $109.69 $1.51 Million - $1.95 Million
17,778 Added 45.95%
56,466 $5.07 Million
Q2 2020

Aug 12, 2020
SELL
$74.18 - $108.93 $101,033 - $148,362
-1,362 Reduced 3.4%
38,688 $4.02 Million
Q1 2020

May 12, 2020
BUY
$63.18 - $85.97 $1.19 Million - $1.62 Million
18,880 Added 89.18%
40,050 $2.93 Million
Q4 2019

Feb 12, 2020
BUY
$73.04 - $95.72 $1.31 Million - $1.71 Million
17,895 Added 546.41%
21,170 $0
Q3 2019

Nov 12, 2019
BUY
$72.82 - $86.52 $2,548 - $3,028
35 Added 1.08%
3,275 $243,000
Q3 2019

Nov 12, 2019
SELL
$72.82 - $86.52 $126,342 - $150,112
-1,735 Reduced 34.87%
3,240 $275,000
Q2 2019

Aug 13, 2019
BUY
$73.52 - $88.7 $133,071 - $160,547
1,810 Added 57.19%
4,975 $423,000
Q1 2019

May 03, 2019
BUY
$63.56 - $88.17 $201,167 - $279,058
3,165 New
3,165 $272,000
Q2 2018

Aug 07, 2018
SELL
$60.85 - $83.98 $195,267 - $269,491
-3,209 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$83.06 - $100.98 $40,699 - $49,480
490 Added 18.02%
3,209 $267,000
Q4 2017

Feb 02, 2018
BUY
$93.56 - $116.6 $67,176 - $83,718
718 Added 35.88%
2,719 $258,000
Q3 2017

Nov 03, 2017
BUY
$109.15 - $138.27 $218,409 - $276,678
2,001
2,001 $234,000

Others Institutions Holding INCY

# of Institutions
644
Shares Held
186M
Call Options Held
714K
Put Options Held
557K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.4B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Greenwood Capital Associates LLC Portfolio

Follow Greenwood Capital Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenwood Capital Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greenwood Capital Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email